Alpha Crest Capital Management LLC Vericel Corp Transaction History

Alpha Crest Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$31.69 - $43.29 $220,625 - $301,384	-6,962 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$35.2 - $52.6 $180,857 - $270,258	-5,138 Reduced 42.46%	6,962 $274,000
Q3 2021 Nov 10, 2021	SELL	$46.35 - $59.75 $395,736 - $510,145	-8,538 Reduced 41.37%	12,100 $590,000
Q2 2021 Aug 12, 2021	BUY	$47.2 - $67.81 $974,113 - $1.4 Million	20,638 New	20,638 $1.08 Million
Q4 2020 Feb 12, 2021	SELL	$18.53 - $31.5 $583,695 - $992,250	-31,500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$14.68 - $19.12 $273,048 - $355,632	18,600 Added 144.19%	31,500 $584,000
Q2 2020 Aug 12, 2020	SELL	$8.5 - $15.82 $207,400 - $386,008	-24,400 Reduced 65.42%	12,900 $178,000
Q1 2020 May 13, 2020	BUY	$7.25 - $19.22 $181,975 - $482,422	25,100 Added 205.74%	37,300 $342,000
Q4 2019 Feb 12, 2020	SELL	$13.77 - $19.2 $61,965 - $86,400	-4,500 Reduced 26.95%	12,200 $212,000
Q3 2019 Nov 12, 2019	BUY	$14.93 - $19.83 $249,331 - $331,161	16,700 New	16,700 $253,000
Q2 2019 Aug 12, 2019	SELL	$15.01 - $18.89 $325,717 - $409,913	-21,700 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$16.23 - $20.29 $352,191 - $440,293	21,700 New	21,700 $380,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.